News

The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the mRNA synthesis and ...
Narry, director of the Center for RNA Research at the Institute for Basic Science (IBS), has uncovered a key cellular mechanism that affects the function of mRNA vaccines and therapeutics.
Researchers have identified cellular factors that regulate the delivery and stability of mRNA to expand the potential of mRNA ...
The mRNA Cancer Vaccines and Therapeutics Market has emerged as one of the most promising sectors within the biotechnology and oncology landscape. mRNA, or messenger RNA, serves as a genetic blueprint ...
Q4 2024 Earnings Call Transcript April 10, 2025 CureVac N.V. misses on earnings expectations. Reported EPS is $-0.16564 EPS, ...
Arcturus Therapeutics (ARCT) announced that the FDA has granted fast track designation for the self-amplifying mRNA vaccine candidate, ...
Drug developers will now have enhanced abilities to rapidly prototype, test, iterate, and scale up their mRNA therapeutics.
President and CEO of Arcturus Therapeutics. "We remain steadfast in our commitment to the U.S. government to develop safe and effective STARR® next-generation mRNA vaccines to protect U.S ...
Cartesian Therapeutics, Inc.’s RNAC share price has dipped by 18.96%, which has investors questioning if this is right time ...
Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...
A team of researchers has uncovered a key cellular mechanism that affects the function of mRNA vaccines and therapeutics. Their study provides the first comprehensive understanding of how mRNA ...
Narry, director of the Center for RNA Research at the Institute for Basic Science (IBS), has uncovered a key cellular mechanism that affects the function of mRNA vaccines and therapeutics.